For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Research Background
Since 2003, with the rapid development of livestock and poultry breeding industry and the implementation of compulsory immunization policy for major animal diseases, China’s market size of animal vaccine has seen rapid growth, the sales value of domestic and foreign manufacturers has increased to 1.4 billion yuan in 2015 from about 3 million yuan, reaching a compound growth rate of 15.1%, of which, hog and poultry vaccine accounted for 81.4% of total sales value.
China’s market size of animal vaccine will maintain stable growth in next ten years, BOABC makes following analyses:
First, vaccine cost for unit livestock and poultry will rise up, which will drive China’s market size of animal vaccine up smoothly. China will speed up transformation and upgrading of livestock and poultry production mode, though total breeding quantity will grow at low speed, the scale level and market share of large groups will increase rapidly, the use of vaccine in productive process will be more scientific and standard.
Second, vaccine products of different classes have greater potential, especially high-end vaccine. Taking swine vaccine for example, the penetration ratio of commercial PVC2 vaccine and FMD vaccine respectively is less than 35% and 15%, future market potential is great, at the same time, scale farms’ demand for high-end products will increase further. In addition, market potential of PRV, diarrhea, M.Hyo. and other products will be released gradually.
Third, compulsory immunization policy adjustment stimulates the growth of animal vaccine market size. China temporarily stop implementing national unified tender for purchasing CSF and PRRS vaccine in 2016, as compulsory product the price difference between commercial CSF vaccine and tender CSF vaccine is more than five times, the market size of CSF vaccine will expand gradually. At the same time, brucellosis and CE vaccine are included in the scope of compulsory immunization, and government tendering procurement will drive the growth of market size of these two products.
However, with the improvement of R&D capacity and mature of productive technology of China’s animal biological product enterprises, the competition of this industry is becoming fierce increasingly, it becomes particular critical that how enterprises make proper development strategy to make them obtain leading advantages in cruel market competition. Facing with this condition, it becomes more important to learn and grasp the development situation and trend of this industry. For example, how to grasp the trend of national policies and regulations for this industry? How about the competition pattern and trend? How about the market size and development potential of different vaccine products? How about the characteristics of different disease vaccines? How about the demand of customers? How about the R&D direction of new products and operation situation of major domestic competitors?
The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation of domestic and foreign vaccine enterprises and future development trend of China’s animal biological product industry on the basis of stating current situation of the industry in 2015 so as to make comprehensive organization and judgment on the competition situation and development trend of China’s animal vaccine industry and assist manufacturers and investment organization to better grasp the development course of China’s animal vaccine industry.
This report is written elaborately based on the data from national level authoritative departments including the National Bureau of Statistics, General Administration of Customs , the MOA, China Institute of Veterinary Drug Control, China Veterinary Drug Association, China Animal Agricultural Association and industrial associations, the data are accurate and authoritative, moreover, this report integrates the views of experts, having high scientificity and prospectiveness. BOABC believes that the report is an important reference material for domestic and foreign animal vaccine manufacturers, investors, associations and research organizations to make strategic decision.